EU plans for better access to low-cost generics and biosimilars in new pharmaceutical strategy

The EU Commission wants to give Europeans more affordable and more accessible medicines, and then the European pharmaceutical industry needs to be strengthened and the safety of the supply chains needs to be top-notch next time we face a pandemic.


An anthropocentric strategy.

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

Related articles